XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Additional Paid In Capital
Retained Deficit
Accumulated  Other Comp. Loss
Beginning balance (in shares) at Dec. 31, 2022   32,826,852        
Beginning balance at Dec. 31, 2022 $ 120,040 $ 328 $ (14,514) $ 261,371 $ (95,595) $ (31,550)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   164,616        
Share-based compensation expense 1,009 $ 2 (764) 1,771    
Net income (loss) from continuing operations for the period 7,146       7,146  
Net income (loss) from discontinued operation for the period 1,554       1,554  
Other comprehensive income (loss) 4,040         4,040
Ending balance (in shares) at Mar. 31, 2023   32,991,468        
Ending balance at Mar. 31, 2023 133,789 $ 330 (15,278) 263,142 (86,895) (27,510)
Beginning balance (in shares) at Dec. 31, 2022   32,826,852        
Beginning balance at Dec. 31, 2022 120,040 $ 328 (14,514) 261,371 (95,595) (31,550)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) from continuing operations for the period 21,061          
Net income (loss) from discontinued operation for the period 5,069          
Other comprehensive income (loss) (1,080)          
Ending balance (in shares) at Sep. 30, 2023   33,108,989        
Ending balance at Sep. 30, 2023 146,554 $ 330 (15,322) 263,641 (69,465) (32,630)
Beginning balance (in shares) at Mar. 31, 2023   32,991,468        
Beginning balance at Mar. 31, 2023 133,789 $ 330 (15,278) 263,142 (86,895) (27,510)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   101,524        
Share-based compensation expense (269)   (24) (245)    
Net income (loss) from continuing operations for the period 9,234       9,234  
Net income (loss) from discontinued operation for the period 906       906  
Other comprehensive income (loss) 100         100
Ending balance (in shares) at Jun. 30, 2023   33,092,992        
Ending balance at Jun. 30, 2023 143,760 $ 330 (15,302) 262,897 (76,755) (27,410)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   15,997        
Share-based compensation expense 724 $ 0 (20) 744    
Net income (loss) from continuing operations for the period 4,681       4,681  
Net income (loss) from discontinued operation for the period 2,609       2,609  
Other comprehensive income (loss) (5,220)         (5,220)
Ending balance (in shares) at Sep. 30, 2023   33,108,989        
Ending balance at Sep. 30, 2023 $ 146,554 $ 330 (15,322) 263,641 (69,465) (32,630)
Beginning balance (in shares) at Dec. 31, 2023 33,322,535 33,322,535        
Beginning balance at Dec. 31, 2023 $ 172,932 $ 333 (16,150) 265,217 (46,184) (30,284)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   3,438        
Share-based compensation expense 662   (2) 664    
Net income (loss) from continuing operations for the period 1,446       1,446  
Net income (loss) from discontinued operation for the period 1,493       1,493  
Other comprehensive income (loss) (994)         (994)
Ending balance (in shares) at Mar. 31, 2024   33,325,973        
Ending balance at Mar. 31, 2024 $ 175,539 $ 333 (16,152) 265,881 (43,245) (31,278)
Beginning balance (in shares) at Dec. 31, 2023 33,322,535 33,322,535        
Beginning balance at Dec. 31, 2023 $ 172,932 $ 333 (16,150) 265,217 (46,184) (30,284)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) from continuing operations for the period (736)          
Net income (loss) from discontinued operation for the period 11,588          
Other comprehensive income (loss) $ (7,440)          
Ending balance (in shares) at Sep. 30, 2024 33,494,483 33,494,483        
Ending balance at Sep. 30, 2024 $ 179,265 $ 335 (16,209) 268,195 (35,332) (37,724)
Beginning balance (in shares) at Mar. 31, 2024   33,325,973        
Beginning balance at Mar. 31, 2024 175,539 $ 333 (16,152) 265,881 (43,245) (31,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   117,991        
Share-based compensation expense 1,332 $ 1 (18) 1,349    
Net income (loss) from continuing operations for the period (1,299)       (1,299)  
Net income (loss) from discontinued operation for the period (302)       (302)  
Other comprehensive income (loss) (5,663)         (5,663)
Ending balance (in shares) at Jun. 30, 2024   33,443,964        
Ending balance at Jun. 30, 2024 169,607 $ 334 (16,170) 267,230 (44,846) (36,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Share-based compensation expense (in shares)   50,519        
Share-based compensation expense 927 $ 1 (39) 965    
Net income (loss) from continuing operations for the period (883)       (883)  
Net income (loss) from discontinued operation for the period 10,397       10,397  
Other comprehensive income (loss) $ (783)         (783)
Ending balance (in shares) at Sep. 30, 2024 33,494,483 33,494,483        
Ending balance at Sep. 30, 2024 $ 179,265 $ 335 $ (16,209) $ 268,195 $ (35,332) $ (37,724)